We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
How to use a quasi-experimental study to evaluate your digital health product.
How we evaluated pre-exposure prophylactic (preventative) treatments for COVID-19.
These reports explain our assessment of the scientific evidence used to lead to regulatory decisions on the safety of medicines or medicines classes.
What we do and how we approach regulating landlords.
The guide, toolkit and further information for GB authorities with responsibility for consumer product safety.
These published standards relate to a number of KPIs in the VMD Deliverables and KPI document.
Explainer for the pharmaceutical industry on the implementation of the Veterinary Medicines Regulation relating to Pharmacovigilance.
Information on good laboratory, manufacturing and distribution practice, good pharmacovigilance practice (GPvP), out-of-specification investigations, inspection metrics and fees.
This guidance summarises our approach to pharmacovigilance
SAPIENT enables interoperability of artificial intelligence (AI) enabled sensors, combined with intelligent fusion and sensor management.
A summary of recent letters and notifications sent to healthcare professionals about medicines and medical devices.
How ear tag manufacturers and suppliers must get cattle ear tags tested to meet Publicly Available Specifications (PAS) 44:2019.
Prescribing or supplying veterinary medicines including requirements for registration and inspection of premises.
SEPs are of growing importance to the UK economy. The IPO is committed to ensuring the current SEPs framework functions effectively to encourage innovation and promote competition.
An agreement between DHSC, NHS England and ABPI to support patient access to medicines, the financial sustainability of the NHS and the UK life sciences sector.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).